Company Overview and News
Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.
Cobalt Blue Holdings (ASX:COB) was only recently minted on the ASX, yet the company has already outlined a rapid growth story.
White Cliff Minerals (ASX:WCN) has near-term gold production potential, and is currently working towards a new JORC Resource for the high-grade Aucu gold project located in the Kyrgyz Republic of central Asia.
Bluechiip (ASX:BCT) has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.
These events are tailor-made for private and professional investors who have exposure to equities, particularly growth stocks - or indeed anyone who is considering putting their money to work in dynamic sectors such as mining, oil and gas, technology and drug discovery.
Cynata Therapeutics (ASX:CYP) is a stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™.
Legend Mining (ASX:LEG) is exploring on one of Australia's host post codes, the Fraser Range of Western Australia, with partner Creasy Group.
Bluechiip Ltd (ASX:BCT) has sold the first Bluechiip starter kit incorporating a tracking technology for biosamples, to the Chinese Centre for Disease, Control and Prevention (CCDC), based in Beijing. The CCDC is an agency of the Chinese Ministry of Health. The Bluechiip system provides temperature and identification tracking solutions for biosamples (any kind of tissue or body fluid). Bluechiip’s patented technology combines secure wireless sample tracking with integrated temperature reading for use in extreme environments, working in temperatures from -196°C to +200°C.
1h - Asif
16h - Asif